IL33 and osteoporosis: In some autoimmune diseases, such as osteoarthritis, psoriasis-associated osteoporosis, and Guillain–Barré syndrome, a pathogenetic immunological crosstalk between vitamin D and IL-33 may be hypothesized, with the combination of hypovitaminosis D–IL-33/ST2 axis activation converging in deleterious effects.